Literature DB >> 33407139

The comparison of efficacy and complications of coblation and radiofrequency thermocoagulation for V2/V3 idiopathic trigeminal neuralgia: a retrospective cohort study of 292 cases.

Chenhui Wang1, Zhi Dou1, Mengwei Yan2, Yuanzhang Tang1, Rui Zhao1, Yujie Han1, Jiaxiang Ni3.   

Abstract

BACKGROUND: Coblation is a novel technique in respect of treating idiopathic trigeminal neuralgia. We aimed to identify the efficacy and complications between radiofrequency thermocoagulation (RFT) and coblation for V2/V3 idiopathic trigeminal neuralgia (ITN) and investigate the risk factors associated with postoperative facial numbness.
METHODS: We retrospectively reviewed our cohort of 292 patients who had undergone RFT or coblation for V2/V3 ITN. The characteristics of the baseline were collected before surgery. Pain scores, the degree of facial numbness and other complications were evaluated at discharge and 1 month, 3 months, 6 months and 12 months after surgery.
RESULTS: Postoperative pain intensity was apparently alleviated in both groups. The initial and 12-months remission rates were 94.0 and 75.3% in coblation group compared with 96.9 and 78.4% in RFT group (P = 0.462, P = 0.585). The degree of postoperative facial numbness tended to be more severe in RFT group at discharge, 1 month, 6 months and 12 months (P = 0.006, P = 0.026, P = 0.004, P = 0.003). Factors significantly associated with more severe facial numbness were procedure of RFT (OR = 0.46, 95%CI: 0.28-0.76, P = 0.002), history of previous RFT at the affected side (OR = 2.33, 95%CI: 1.21-4.48, P = 0.011), and ITN with concomitant continuous pain (OR = 0.36, 95%CI: 0.18-0.71, P = 0.004).
CONCLUSION: Coblation could reduce the degree of postoperative facial numbness for ITN, and the efficacy was no less effective than RFT. History of previous RFT at the affected side, procedure of RFT, ITN with concomitant continuous pain was identified as significant factors of the development of postoperative facial numbness.

Entities:  

Keywords:  Coblation; Radiofrequency thermocoagulation; Trigeminal neuralgia

Mesh:

Year:  2021        PMID: 33407139      PMCID: PMC7788920          DOI: 10.1186/s12871-020-01224-2

Source DB:  PubMed          Journal:  BMC Anesthesiol        ISSN: 1471-2253            Impact factor:   2.217


  28 in total

1.  Long-term Follow-up of Patients Treated with Percutaneous Radiofrequency Thermocoagulation via the Foramen Rotundum for Isolated Maxillary Nerve Idiopathic Trigeminal Neuralgia.

Authors:  Bing Ran; Jun Wei; Qiong Zhong; Min Fu; Jun Yang; XinRong Chen; XinYuan Wen; Yong Liu; Yun Wu; Xin Deng
Journal:  Pain Med       Date:  2019-07-01       Impact factor: 3.750

2.  Factors Predicting Successful Outcomes for Percutaneous Radiofrequency Thermocoagulation in Patients With Idiopathic Trigeminal Neuralgia: Implications for Surgical Decision Making.

Authors:  Xiuhua Li; Shuyue Zheng; Liqiang Yang; Zhao Cao; Jiaxiang Ni; Yuqi Zhang
Journal:  Pain Pract       Date:  2019-05-28       Impact factor: 3.183

3.  The Role of Percutaneous Radiofrequency Thermocoagulation for Persistent or Recurrent Trigeminal Neuralgia After Surgery.

Authors:  Pengfei Liu; Wenxiang Zhong; Chenlong Liao; Min Yang; Wenchuan Zhang
Journal:  J Craniofac Surg       Date:  2016-11       Impact factor: 1.046

4.  Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition.

Authors: 
Journal:  Cephalalgia       Date:  2018-01       Impact factor: 6.292

5.  Long-term efficacy and safety of internal neurolysis for trigeminal neuralgia without neurovascular compression.

Authors:  Andrew L Ko; Alp Ozpinar; Albert Lee; Ahmed M Raslan; Shirley McCartney; Kim J Burchiel
Journal:  J Neurosurg       Date:  2015-02-13       Impact factor: 5.115

6.  Incidence of facial pain in the general population.

Authors:  Joseph S H A Koopman; Jeanne P Dieleman; Frank J Huygen; Marissa de Mos; Carola G M Martin; Miriam C J M Sturkenboom
Journal:  Pain       Date:  2009-09-26       Impact factor: 6.961

7.  Incidence and clinical features of trigeminal neuralgia, Rochester, Minnesota, 1945-1984.

Authors:  S Katusic; C M Beard; E Bergstralh; L T Kurland
Journal:  Ann Neurol       Date:  1990-01       Impact factor: 10.422

8.  Gamma knife radiosurgery for trigeminal neuralgia associated with multiple sclerosis.

Authors:  C Leland Rogers; Andrew G Shetter; Francisco A Ponce; Jeffrey A Fiedler; Kris A Smith; Burton L Speiser
Journal:  J Neurosurg       Date:  2002-12       Impact factor: 5.115

9.  Radiofrequency thermocoagulation for V2/V3 idiopathic trigeminal neuralgia: effect of treatment temperatures on long-term clinical outcomes: A Cohort Study.

Authors:  Peng Yao; Yi-Yong Deng; Tao Hong; Zhi-Bin Wang; Jia-Ming Ma; Yong-Qiang Zhu; Hong-Xi Li; Yuan-Yuan Ding; Shi-Nong Pan
Journal:  Medicine (Baltimore)       Date:  2016-06       Impact factor: 1.889

10.  Treatment of bilateral idiopathic trigeminal neuralgia by radiofrequency thermocoagulation at different temperatures.

Authors:  Peng Yao; Tao Hong; Zhi-Bin Wang; Jia-Ming Ma; Yong-Qiang Zhu; Hong-Xi Li; Yuan-Yuan Ding; Chang-Lin Jiang; Shi-Nong Pan
Journal:  Medicine (Baltimore)       Date:  2016-07       Impact factor: 1.889

View more
  3 in total

Review 1.  The trigeminal pathways.

Authors:  Louis-Marie Terrier; Nouchine Hadjikhani; Christophe Destrieux
Journal:  J Neurol       Date:  2022-03-06       Impact factor: 4.849

2.  Cardiovascular response to Gasserian ganglion ablation on trigeminal neuralgia under local anesthesia: a retrospective single-blind case-control study.

Authors:  Dingliang Zhao; Jing Li; Chao Ma; Ying Huang; Gaojian Tao
Journal:  BMC Anesthesiol       Date:  2022-04-11       Impact factor: 2.217

3.  Long-term outcomes and predictors of percutaneous radiofrequency thermocoagulation of Gasserian ganglion for maxillary trigeminal neuralgia: a retrospective analysis of 1070 patients with minimum 2-year follow-up.

Authors:  Wenxing Zhao; Liqiang Yang; Ansong Deng; Zongjie Chen; Liangliang He
Journal:  Ann Med       Date:  2022-12       Impact factor: 5.348

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.